![Bullish](/static/images/ih2-bull.png)
Recent SMMT News
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 06/13/2024 06:03:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 10:18:31 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 10:05:37 AM
- Summit Raises $200 Million; Also Expands License Territories for Ivonescimab • Business Wire • 06/03/2024 09:30:00 AM
- Ivonescimab Manuscript for HARMONi-A Clinical Trial Results Published in JAMA • Business Wire • 06/01/2024 12:00:00 PM
- Ivonescimab in Combination with Chemotherapy Approved in China by NMPA for 2L+ EGFRm NSCLC based on HARMONi-A Clinical Trial: Positive Trend Observed in Overall Survival towards Ivonescimab Plus Chemotherapy • Business Wire • 05/31/2024 11:00:00 PM
- Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 05/30/2024 10:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/30/2024 08:48:30 PM
- Ivonescimab Monotherapy Decisively Beats Pembrolizumab Monotherapy Head-to-Head, Achieves Statistically Significant Superiority in PFS in First-Line Treatment of Patients with PD-L1 Positive NSCLC in China • Business Wire • 05/30/2024 06:29:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/24/2024 12:35:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2024 12:03:57 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/13/2024 11:48:42 AM
- Summit Therapeutics Reports Financial Results and Operational Progress for the First Quarter Ended March 31, 2024 • Business Wire • 05/01/2024 11:00:00 AM
- Summit Therapeutics to Host First Quarter 2024 Financial Results & Operational Progress Call on May 1, 2024 • Business Wire • 04/24/2024 08:30:00 PM
- Summit Therapeutics Appoints Dr. Mostafa Ronaghi, Renowned Executive and Genomicist, to its Board of Directors • Business Wire • 04/11/2024 08:30:00 PM
- Summit Therapeutics to Present at the Stifel 2024 Targeted Oncology Forum • Business Wire • 04/10/2024 11:00:00 AM
- Promising Intracranial Anti-Tumor Activity and Safety Data for Ivonescimab in NSCLC Patients with Brain Metastases Featured at ELCC 2024 • Business Wire • 03/22/2024 11:00:00 AM
- Intracranial Anti-Tumor Activity and Safety of Ivonescimab in NSCLC Patients with Brain Metastases to be Featured at ELCC 2024 • Business Wire • 03/14/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 09:05:09 PM
- Summit Therapeutics to Present at the Barclays 26th Annual Global Healthcare Conference • Business Wire • 03/05/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2024 01:05:51 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 02/20/2024 12:55:18 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/20/2024 12:32:56 PM
- Summit Therapeutics Reports Financial Results and Operational Progress for the Fourth Quarter and Year Ended December 31, 2023 • Business Wire • 02/20/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 10:25:38 PM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM